Delivery Order SPE2DB20D6036-SPE2DB23FC8JG

This is a delivery order for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a firm-fixed price contract with a ceiling value of $3,756.72 and a completion date of September 27, 2024. The contract does not have a set-aside designation. As one of Amerisourcebergen's numerous federal contract awards, this delivery order is likely part of the...

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division located in Conshohocken, Pennsylvania. The $3,721.90 contract is for the supply of HYPERRAB 300 UNIT/ML VIALML, a pharmaceutical product. The award represents a task order placed against an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through December 31, 2025. This IDC...

<p>The Defense Logistics Agency awarded a $6,613 delivery order to Amerisourcebergen Drug Corporation for 4561584476 HYPERRAB 300 UNIT/ML VIAL 3ML pharmaceutical products. The firm fixed price order is being fulfilled from the contractor's Conshohocken, Pennsylvania location through August 14, 2023 to support the Department of Defense. No additional details were provided regarding the original solicitation or use of the pharmaceutical products procured under this order.</p>

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The ceiling value of the contract is $3,756.72, with an ultimate completion date of August 6, 2024. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a specific medical product, at a ceiling value of $17,908.00. The contract is a firm fixed-price delivery order with a completion date of March 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...

<p>Defense Logistics Agency awarded a $18,385.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562437662 HYPERRAB 300 UNIT/ML VIAL 5ML. The order is for pharmaceutical products to be delivered by October 31, 2023 from the contractor's location in Conshohocken, Pennsylvania. No set-aside provisions were applied to this award made under an existing prime vendor contract vehicle to supply pharmaceuticals in support of DLA's medical logistics programs.</p>

This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued up to $999,999,999 through December 2025, provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The specific delivery order, valued at $22,505.40, is for 4,565,424,924 units...

The Defense Logistics Agency awarded a $1,838.58 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561501176 HYPERRAB 300 UNIT/ML VIAL 5ML pharmaceutical products. The contract has a period of performance from July 14, 2023 through August 4, 2023, with all work to be performed by the prime contractor in Conshohocken, Pennsylvania. No additional details were provided regarding major subcontractors or the Defense Logistics Agency's programs that this delivery order...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The firm-fixed-price contract, valued at $37,567.00, has a completion date of September 4, 2024. This order is a part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The IDC...

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300UNIT/ML 1S, a medical product, with a ceiling value of $9,304.50 and a completion date of May 7, 2024. The contract is Firm Fixed Price and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...